Vilin Bio Med Key Ratios
NSE: VILINBIO
₹49.25
₹2.30
(4.90%)
As on 02-Sep-2026IST
Market cap
₹72 Cr
Revenue (TTM)
₹42 Cr
P/E Ratio
37.1
P/B Ratio
2.5
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | 185.37 | 50.85 | 29.25 |
| EBIT | -- | -- | 326.15 | 6.53 | 38.19 |
| Net Profit | -- | -- | 762.66 | 15.71 | 73.90 |
| EPS | -- | -- | 689.08 | 0.36 | 53.79 |
| Book Value | -- | -- | 12.53 | 20.13 | 15.83 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-26 | Mar-25 | Mar-24 |
| EBIT-Margin
| 5.28 | 8.05 | 6.88 | 4.61 | 4.34 |
| Net Margin
| 2.34 | 3.49 | 4.56 | 1.46 | 1.01 |
| Return on equity
| 3.15 | 4.74 | 7.50 | 0.97 | 0.97 |
| Return on Capital
| 6.45 | 8.17 | 10.73 | 4.16 | 4.47 |
| Return on Assets
| 2.51 | 3.15 | 6.15 | 0.74 | 0.65 |
| Debt to Equity (x)
| -- | -- | 0.01 | 0.11 | 0.30 |
Profitability
ROCE
10.73
Lower than Peers by 4.17
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Vilin Bio Med
|
10.73
|
4.16
|
4.47
|
17.17
|
4.31
|
|
Peer Median
|
14.90
|
14.72
|
18.85
|
11.60
|
--
|
ROE
7.50
Lower than Peers by 5.27
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Vilin Bio Med
|
7.50
|
0.97
|
0.97
|
13.78
|
0.46
|
|
Peer Median
|
12.77
|
11.67
|
14.92
|
11.46
|
--
|
ROA
6.15
Lower than Peers by 0.94
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Vilin Bio Med
|
6.15
|
0.74
|
0.65
|
7.97
|
0.24
|
|
Peer Median
|
7.09
|
7.86
|
9.06
|
6.44
|
--
|
EBIT Margin
6.88
Lower than Peers by 7.19
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Vilin Bio Med
|
6.88
|
4.61
|
4.34
|
19.54
|
4.87
|
|
Peer Median
|
14.07
|
15.03
|
14.71
|
12.37
|
--
|
Net Margin
4.56
Lower than Peers by 3.98
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Vilin Bio Med
|
4.56
|
1.46
|
1.01
|
10.09
|
0.30
|
|
Peer Median
|
8.54
|
9.33
|
8.49
|
10.02
|
--
|
Cash Profit Margin
5.24
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Vilin Bio Med
|
5.24
|
2.21
|
1.85
|
11.47
|
2.25
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
185.37
Higher than Peers by 172.33
Year on year growth in net sales
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Vilin Bio Med
|
185.37
|
-6.30
|
28.36
|
9.79
|
-4.27
|
|
Peer Median
|
13.04
|
10.27
|
11.85
|
9.08
|
--
|
EBIT Growth
326.15
Higher than Peers by 308.98
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Vilin Bio Med
|
326.15
|
-0.61
|
-71.45
|
340.16
|
-5.32
|
|
Peer Median
|
17.18
|
24.15
|
28.00
|
-3.12
|
--
|
Net Profit Growth
762.66
Higher than Peers by 737.82
Year on year growth in profit after tax
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Vilin Bio Med
|
762.66
|
37.68
|
-86.96
|
3,605.36
|
-72.30
|
|
Peer Median
|
24.83
|
30.29
|
36.51
|
-0.85
|
--
|
EPS Growth
689.08
Higher than Peers by 671.28
Year on year growth in earnings per share
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Vilin Bio Med
|
689.08
|
37.71
|
-90.70
|
2,974.45
|
-72.32
|
|
Peer Median
|
17.80
|
24.50
|
--
|
-6.82
|
--
|
Book Value Growth
23.02
--
Year on year growth in book value per share
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Vilin Bio Med
|
23.02
|
0.98
|
113.91
|
44.37
|
0.46
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.01
Lower than Peers by 0.20
Total debt / Net worth
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Vilin Bio Med
|
0.01
|
0.11
|
0.30
|
0.46
|
0.72
|
|
Peer Median
|
0.21
|
0.23
|
0.20
|
0.15
|
--
|
Short term debt to equity ratio
0.01
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Vilin Bio Med
|
0.01
|
0.11
|
0.29
|
0.42
|
0.62
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
4.25
Higher than Peers by 2.42
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Vilin Bio Med
|
4.25
|
4.30
|
2.01
|
1.24
|
2.22
|
|
Peer Median
|
1.83
|
1.79
|
1.96
|
2.08
|
--
|
Quick Ratio
3.13
Higher than Peers by 1.93
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Vilin Bio Med
|
3.13
|
3.35
|
1.53
|
1.10
|
1.79
|
|
Peer Median
|
1.20
|
1.47
|
1.44
|
1.58
|
--
|
Interest Coverage
42.29
Higher than Peers by 34.13
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Vilin Bio Med
|
42.29
|
1.36
|
1.29
|
3.75
|
1.09
|
|
Peer Median
|
8.17
|
9.42
|
8.58
|
15.41
|
--
|
Operating Efficiency
Debtors to sales
37.75
Higher than Peers by 12.61
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Vilin Bio Med
|
37.75
|
57.77
|
35.96
|
45.48
|
69.43
|
|
Peer Median
|
25.14
|
25.82
|
26.12
|
22.96
|
--
|
Asset Turnover
1.35
Higher than Peers by 0.61
Sales / Average Total Assets
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Vilin Bio Med
|
1.35
|
0.49
|
0.63
|
0.79
|
0.82
|
|
Peer Median
|
0.73
|
0.75
|
0.77
|
0.65
|
--
|
Receivable days
105.84
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Vilin Bio Med
|
105.84
|
175.47
|
130.30
|
198.42
|
251.12
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
50.21
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Vilin Bio Med
|
50.21
|
109.42
|
61.73
|
46.88
|
70.76
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
23.25
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Vilin Bio Med
|
23.25
|
45.95
|
44.10
|
46.59
|
30.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
132.80
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Vilin Bio Med
|
132.80
|
238.93
|
147.94
|
198.71
|
291.87
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
28.97
Lower than Peers by 13.09
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Vilin Bio Med
|
28.97
|
127.26
|
163.23
|
--
|
--
|
|
Peer Median
|
42.06
|
39.70
|
33.48
|
37.74
|
--
|
Price / Book Value
1.97
Lower than Peers by 2.62
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Vilin Bio Med
|
1.97
|
1.23
|
1.16
|
--
|
--
|
|
Peer Median
|
4.59
|
3.72
|
4.21
|
3.22
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Vilin Bio Med
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.10
|
0.16
|
0.21
|
0.57
|
--
|
EV/EBITDA
17.10
Lower than Peers by 12.86
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Vilin Bio Med
|
17.10
|
24.67
|
23.91
|
5.72
|
11.12
|
|
Peer Median
|
29.97
|
30.23
|
29.90
|
28.81
|
--
|
Market Cap
56
Lower than Peers by 4,949
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Vilin Bio Med
|
56
|
28
|
27
|
--
|
--
|
|
Peer Median
|
5,004
|
4,851
|
2,099
|
15,272
|
--
|
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
